Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 53Recruiting 22Terminated 14Unknown 11Active not recruiting 11Withdrawn 2Suspended 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 212Thoracic 5Genitourinary 3Sarcoma 2Head & Neck 2Gynecologic 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1Endocrine 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 549Triple Negative Breast Neoplasms 84Neoplasms 20Lung Neoplasms 16Colorectal Neoplasms 16Neoplasm Metastasis 15Advanced Breast Cancer 15Prostatic Neoplasms 13Motor Activity 13HER2-positive Breast Cancer 12Carcinoma, Non-Small-Cell Lung 12Carcinoma, Intraductal, Noninfiltrating 11Breast Cancer Lymphedema 11Stomach Neoplasms 10Anxiety Disorders 10Endometrial Neoplasms 9Uterine Cervical Neoplasms 8Ovarian Neoplasms 8Depression 8Pain 7Cardiotoxicity 7Brain Neoplasms 7Pain, Postoperative 6Melanoma 6Lymphedema 6Head and Neck Neoplasms 6Colonic Neoplasms 6Pancreatic Neoplasms 5Liver Neoplasms 5Anatomic Stage I Breast Cancer AJCC v8 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Hepatocellular × Breast × Clear all
NCT06724263 2024-12-09

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Tasly Biopharmaceuticals Co., Ltd.

Phase 2 Not yet recruiting
120 enrolled
BreastGastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡